Trial Profile

Phase I Double Blind Placebo Controlled Safety Study of ex Vivo Treatment of Kidneys From Deceased Donors With Renaparin, Followed by Transplantation to Study Population

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Jul 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Renaparin (Primary)
Indications Delayed graft function
Focus Adverse reactions
Acronyms RENAPAIR 01
Sponsors Corline Biomedical

Most Recent Events

30 Jun 2020 Status changed from active, no longer recruiting to completed.
10 Jun 2020 Top-line results presented in the Corline Biomedical Media Release.
12 May 2020 According to a Corline Biomedical media release, it plans to present the results of the study in June.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com